UPDATE 1-Novartis digs deeper into cancer with up to $750 mln Aduro deal By: Reuters: Company News March 30, 2015 at 12:43 PM EDT * Novartis also picks top scientist to lead immuno-oncology (Adds details on Aduro's planned IPO, analyst comment) Read More >> Related Stocks: Aduro Biotech